{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:49:18Z","timestamp":1791820158681,"version":"4.3.4"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"DOI":"10.1007\/s12149-026-02304-y","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:10:58Z","timestamp":1791817858000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Head-to-head comparison of \u2076\u2078Ga-FAPI and \u00b9\u2078F-FDG PET\/CT in intracranial space-occupying lesions"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9224-8965","authenticated-orcid":false,"given":"Raydel BrianKwee","family":"Amalo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aih","family":"Cahyani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendra","family":"Budiawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Budi","family":"Darmawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kharisma Perdani","family":"Kusumahstuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arifudin","family":"Achmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basuki","family":"Hidayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achmad Hussein Sundawa","family":"Kartamihardja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"key":"2304_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1436009","author":"Y Liu","year":"2024","unstructured":"Liu Y, Ding H, Cao J, Liu G, Chen Y, Huang Z. [68Ga]Ga-FAPI PET\/CT in brain tumors: comparison with [18F]F-FDG PET\/CT. Front Oncol. 2024. https:\/\/doi.org\/10.3389\/fonc.2024.1436009.","journal-title":"Front Oncol"},{"key":"2304_CR2","doi-asserted-by":"publisher","unstructured":"Ko\u00e7 ZP, Kara P\u00d6, Da\u01e7tekin A. Detection of unknown primary tumor in patients presented with brain metastasis by F-18 fluorodeoxyglucose positron emission tomography\/computed tomography. CNS Oncol. 2018;7(2). https:\/\/doi.org\/10.2217\/cns-2017-0018.","DOI":"10.2217\/cns-2017-0018"},{"issue":"5","key":"2304_CR3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nrneurol.2017.44","volume":"13","author":"KJ Langen","year":"2017","unstructured":"Langen KJ, Galldiks N, Hattingen E, Shah NJ. Advances in neuro-oncology imaging. Nat Rev Neurol. 2017;13(5):279\u201389. https:\/\/doi.org\/10.1038\/nrneurol.2017.44.","journal-title":"Nat Rev Neurol"},{"key":"2304_CR4","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.220749","author":"Y Mori","year":"2023","unstructured":"Mori Y, Dendl K, Cardinale J, Kratochwil C, Giesel FL, Haberkorn U. FAPI PET: fibroblast activation protein inhibitor use in oncologic and nononcologic disease. Radiology. 2023. https:\/\/doi.org\/10.1148\/radiol.220749.","journal-title":"Radiology"},{"key":"2304_CR5","doi-asserted-by":"publisher","unstructured":"Gilardi L, Farulla LSA, Demirci E, Clerici I, Sal\u00e8 EO, Ceci F. Imaging Cancer-Associated Fibroblasts (CAFs) with FAPi PET. Biomedicines MDPI. 2022;10(3). https:\/\/doi.org\/10.3390\/biomedicines10030523.","DOI":"10.3390\/biomedicines10030523"},{"issue":"18","key":"2304_CR6","doi-asserted-by":"publisher","first-page":"6935","DOI":"10.7150\/thno.103399","volume":"14","author":"D Ruan","year":"2024","unstructured":"Ruan D, Sun J, Han C, et al. 68Ga-FAPI-46 PET\/CT in the evaluation of gliomas: comparison with 18F-FDG PET\/CT and contrast-enhanced MRI. Theranostics. 2024;14(18):6935\u201346. https:\/\/doi.org\/10.7150\/thno.103399.","journal-title":"Theranostics"},{"issue":"12","key":"2304_CR7","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1007\/s00259-019-04444-y","volume":"46","author":"M R\u00f6hrich","year":"2019","unstructured":"R\u00f6hrich M, Loktev A, Wefers AK, et al. IDH-wildtype glioblastomas and grade III\/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein\u2013specific PET\/CT. Eur J Nucl Med Mol Imaging. 2019;46(12):2569\u201380. https:\/\/doi.org\/10.1007\/s00259-019-04444-y.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2304_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15041193","author":"Y Dong","year":"2023","unstructured":"Dong Y, Zhou H, Alhaskawi A, et al. The superiority of fibroblast activation protein inhibitor (FAPI) PET\/CT versus FDG PET\/CT in the diagnosis of various malignancies. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15041193.","journal-title":"Cancers (Basel)"},{"key":"2304_CR9","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262790","author":"B Gu","year":"2022","unstructured":"Gu B, Xu X, Zhang J, et al. The added value of 68Ga-FAPI-PET\/CT in patients with head and neck cancer of unknown primary with 18F-FDG negative findings. J Nucl Med. 2022. https:\/\/doi.org\/10.2967\/jnumed.121.262790.","journal-title":"J Nucl Med"},{"issue":"3","key":"2304_CR10","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2967\/jnumed.123.266556","volume":"65","author":"B Gu","year":"2024","unstructured":"Gu B, Yang Z, Du X, et al. Imaging of tumor stroma using 68Ga-FAPI PET\/CT to improve diagnostic accuracy of primary tumors in head and neck cancer of unknown primary: a comparative imaging trial. J Nucl Med. 2024;65(3):365\u201371. https:\/\/doi.org\/10.2967\/jnumed.123.266556.","journal-title":"J Nucl Med"},{"key":"2304_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-025-00843-7","author":"T Li","year":"2025","unstructured":"Li T, Zhang J, Yan Y, et al. Head-to-head comparison of 18F-FDG and 68Ga-FAPI PET\/CT in common gynecological malignancies. Cancer Imaging. 2025. https:\/\/doi.org\/10.1186\/s40644-025-00843-7.","journal-title":"Cancer Imaging"},{"key":"2304_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/life13091821","author":"P Guglielmo","year":"2023","unstructured":"Guglielmo P, Alongi P, Baratto L, et al. Head-to-head comparison of FDG and radiolabeled FAPI PET: a systematic review of the literature. Life. 2023. https:\/\/doi.org\/10.3390\/life13091821.","journal-title":"Life"},{"issue":"1","key":"2304_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-025-03511-5","volume":"30","author":"L Chen","year":"1990","unstructured":"Chen L, Yang F, Yang J, et al. Epidemiological trends of burden of brain and CNS cancer at global, regional, and national level: a trend analysis study from 1990 to 2021. Eur J Med Res. 1990;30(1):1268. https:\/\/doi.org\/10.1186\/s40001-025-03511-5.","journal-title":"Eur J Med Res"},{"issue":"03","key":"2304_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4103\/1793-5482.121688","volume":"8","author":"A Saha","year":"2013","unstructured":"Saha A, Ghosh S, Roy C, Choudhury K, Chakrabarty B, Sarkar R. Demographic and clinical profile of patients with brain metastases: a retrospective study. Asian J Neurosurg. 2013;8(03):157\u201361. https:\/\/doi.org\/10.4103\/1793-5482.121688.","journal-title":"Asian J Neurosurg"},{"key":"2304_CR15","doi-asserted-by":"publisher","DOI":"10.15562\/ijn.v4i1.142","author":"J Wahyuhadi","year":"2021","unstructured":"Wahyuhadi J, Raiyan Pratama MF, Zahra Wathoni RT, Basuki H. The Indonesian Central Nervous System Tumors Registry (Ina-CTR): 7 years result from single institution of primary brain tumor epidemiology. Indones J Neurosurg. 2021. https:\/\/doi.org\/10.15562\/ijn.v4i1.142.","journal-title":"Indones J Neurosurg"},{"key":"2304_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1079597","author":"J Cao","year":"2004","unstructured":"Cao J, Yan W, Zhan Z, Hong X, Yan H. Epidemiology and risk stratification of low-grade gliomas in the United States, 2004\u20132019: a competing-risk regression model for survival analysis. Front Oncol. 2004. https:\/\/doi.org\/10.3389\/fonc.2023.1079597.","journal-title":"Front Oncol"},{"key":"2304_CR17","doi-asserted-by":"publisher","unstructured":"Bauchet L, Rigau V, Mathon B, Darlix A. Epidemiological analysis of adult-type diffuse lower-grade gliomas and incidence and prevalence estimates of diffuse IDH-mutant gliomas in France. Neurochirurgie. Elsevier Masson s.r.l. 2025;71(3). https:\/\/doi.org\/10.1016\/j.neuchi.2024.101627","DOI":"10.1016\/j.neuchi.2024.101627"},{"key":"2304_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/biom14121585","author":"A Garaba","year":"2024","unstructured":"Garaba A, Panciani PP, Da\u2019ana A, et al. Unveiling the hidden burden: a systematic review on the prevalence and clinical implications of calcified brain metastases. Biomolecules. 2024. https:\/\/doi.org\/10.3390\/biom14121585.","journal-title":"Biomolecules"},{"key":"2304_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jocn.2020.08.006","volume":"80","author":"HP Bhambhvani","year":"2020","unstructured":"Bhambhvani HP, Granucci M, Rodrigues A, Kakusa BW, Hayden Gephart M. The primary sites leading to brain metastases: shifting trends at a tertiary care center. J Clin Neurosci. 2020;80:121\u20134. https:\/\/doi.org\/10.1016\/j.jocn.2020.08.006.","journal-title":"J Clin Neurosci"},{"issue":"1","key":"2304_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2217\/cns.14.51","volume":"4","author":"F Bertolini","year":"2015","unstructured":"Bertolini F, Spallanzani A, Fontana A, Depenni R, Luppi G. Brain metastases: an overview. CNS Oncol. 2015;4(1):37\u201346. https:\/\/doi.org\/10.2217\/cns.14.51.","journal-title":"CNS Oncol"},{"key":"2304_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s43055-020-00342-8","author":"MA Zidan","year":"2020","unstructured":"Zidan MA, Hassan RS, El-Noueam KI, Zakaria YM. Brain metastases assessment by FDG-PET\/CT: can it eliminate the necessity for dedicated brain imaging? Egypt J Radiol Nucl Med. 2020. https:\/\/doi.org\/10.1186\/s43055-020-00342-8.","journal-title":"Egypt J Radiol Nucl Med"},{"issue":"3","key":"2304_CR22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.trecan.2018.01.003","volume":"4","author":"M Valiente","year":"2018","unstructured":"Valiente M, Ahluwalia MS, Boire A, et al. The evolving landscape of brain metastasis. Trends Cancer. 2018;4(3):176\u201396. https:\/\/doi.org\/10.1016\/j.trecan.2018.01.003.","journal-title":"Trends Cancer"},{"key":"2304_CR23","doi-asserted-by":"publisher","unstructured":"Achrol AS, Rennert RC, Anders C, et al. Brain metastases. Nat Rev Dis Primers. Nat Publishing Group. 2019;5(1). https:\/\/doi.org\/10.1038\/s41572-018-0055-y.","DOI":"10.1038\/s41572-018-0055-y"},{"issue":"4","key":"2304_CR24","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrc.2016.25","volume":"16","author":"PS Steeg","year":"2016","unstructured":"Steeg PS. Targeting metastasis. Nat Rev Cancer. 2016;16(4):201\u201318. https:\/\/doi.org\/10.1038\/nrc.2016.25.","journal-title":"Nat Rev Cancer"},{"key":"2304_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11020364","author":"M Martucci","year":"2023","unstructured":"Martucci M, Russo R, Schimperna F, et al. Magnetic resonance imaging of primary adult brain tumors: state of the art and future perspectives. Biomedicines. 2023. https:\/\/doi.org\/10.3390\/biomedicines11020364.","journal-title":"Biomedicines"},{"issue":"9","key":"2304_CR26","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.53350\/pjmhs211594009","volume":"15","author":"S Sarfraz","year":"2021","unstructured":"Sarfraz S, Farzana M. Comparison of diagnostic accuracy of magnetic resonance spectroscopy with conventional magnetic resonance imaging for brain tumors and correlation with histopathology as gold standard. Pak J Med Health Sci. 2021;15(9):4009\u201311. https:\/\/doi.org\/10.53350\/pjmhs211594009.","journal-title":"Pak J Med Health Sci"},{"key":"2304_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2022.104679","author":"N Haydar","year":"2022","unstructured":"Haydar N, Alyousef K, Alanan U, et al. Role of magnetic resonance imaging (MRI) in grading gliomas comparable with pathology: a cross-sectional study from Syria. Ann Med Surg (Lond). 2022. https:\/\/doi.org\/10.1016\/j.amsu.2022.104679.","journal-title":"Ann Med Surg (Lond)"},{"key":"2304_CR28","doi-asserted-by":"publisher","DOI":"10.4103\/2152-7806.111298","author":"K Fink","year":"2013","unstructured":"Fink K, Fink J. Imaging of brain metastases. Surg Neurol Int. 2013. https:\/\/doi.org\/10.4103\/2152-7806.111298.","journal-title":"Surg Neurol Int"},{"key":"2304_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16152667","author":"K Bhattacharya","year":"2024","unstructured":"Bhattacharya K, Mahajan A, Mynalli S. Imaging recommendations for diagnosis, staging, and management of central nervous system neoplasms in adults: CNS metastases. Cancers (Basel). 2024. https:\/\/doi.org\/10.3390\/cancers16152667.","journal-title":"Cancers (Basel)"},{"key":"2304_CR30","doi-asserted-by":"publisher","unstructured":"Abbasi S, Dehghani M, Khademi S, et al. Revolutionizing cancer diagnosis and dose biodistribution: a meta-analysis of [68ga] FAPI- 46 vs. [18f] FDG imaging. Syst Rev. 2025;14(1). https:\/\/doi.org\/10.1186\/s13643-025-02835-x.","DOI":"10.1186\/s13643-025-02835-x"},{"issue":"7","key":"2304_CR31","doi-asserted-by":"publisher","first-page":"4450","DOI":"10.21037\/qims-24-82","volume":"14","author":"T Hua","year":"2024","unstructured":"Hua T, Chen M, Fu P, et al. Heterogeneity of fibroblast activation protein expression in the microenvironment of an intracranial tumor cohort: head-to-head comparison of gallium-68 FAP inhibitor-04 (68Ga-FAPi-04) and fluoride-18 fluoroethyl-L-tyrosine (18F-FET) in positron emission tomography-computed tomography imaging. Quant Imaging Med Surg. 2024;14(7):4450\u201363. https:\/\/doi.org\/10.21037\/qims-24-82.","journal-title":"Quant Imaging Med Surg"},{"key":"2304_CR32","doi-asserted-by":"publisher","unstructured":"Chandekar KR, Prashanth A, Vinjamuri S, Kumar R. FAPI PET\/CT Imaging\u2014An Updated Review. Diagnostics. Multidisciplinary Digital Publishing Institute (MDPI). 2023;13(12). https:\/\/doi.org\/10.3390\/diagnostics13122018","DOI":"10.3390\/diagnostics13122018"},{"key":"2304_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1293847","author":"P Kanel","year":"2023","unstructured":"Kanel P, Carli G, Vangel R, Roytman S, Bohnen NI. Challenges and innovations in brain PET analysis of neurodegenerative disorders: a mini-review on partial volume effects, small brain region studies, and reference region selection. Front Neurosci. 2023. https:\/\/doi.org\/10.3389\/fnins.2023.1293847.","journal-title":"Front Neurosci"},{"issue":"8","key":"2304_CR34","doi-asserted-by":"publisher","first-page":"722","DOI":"10.3390\/ph14080722","volume":"14","author":"A Pietrzak","year":"2021","unstructured":"Pietrzak A, Marsza\u0142ek A, Piotrowski T, et al. Primary and Metastatic Brain Tumours Assessed with the Brain and Torso [18F]FDG PET\/CT Study Protocol\u201410 Years of Single-Institutional Experiences. Pharmaceuticals. 2021;14(8):722. https:\/\/doi.org\/10.3390\/ph14080722.","journal-title":"Pharmaceuticals"},{"issue":"2","key":"2304_CR35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.5603\/rpOr.a2022.0021","volume":"27","author":"A Pietrzak","year":"2022","unstructured":"Pietrzak A, Marsza\u0142ek A, Piotrowski T, et al. The utility of 18F-FDG PET\/CT in brain tumours diagnosis. Rep Pract Oncol Radiother. 2022;27(2):235\u201340. https:\/\/doi.org\/10.5603\/rpOr.a2022.0021.","journal-title":"Rep Pract Oncol Radiother"},{"issue":"2","key":"2304_CR36","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/cns.14036","volume":"29","author":"K Cheng","year":"2023","unstructured":"Cheng K, Duan Q, Hu J, et al. Evaluation of postcontrast images of intracranial tumors at 7T and 3T MRI: An intra-individual comparison study. CNS Neurosci Ther. 2023;29(2):559\u201365. https:\/\/doi.org\/10.1111\/cns.14036.","journal-title":"CNS Neurosci Ther"},{"issue":"5","key":"2304_CR37","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/neuonc\/noz003","volume":"21","author":"N Galldiks","year":"2019","unstructured":"Galldiks N, Langen KJ, Albert NL, et al. PET imaging in patients with brain metastasis\u2014report of the RANO\/PET group. Neuro Oncol. 2019;21(5):584\u201395. https:\/\/doi.org\/10.1093\/neuonc\/noz003.","journal-title":"Neuro Oncol"},{"key":"2304_CR38","doi-asserted-by":"publisher","unstructured":"Chung KJ, Abdelhafez YG, Spencer BA, et al. Quantitative PET imaging and modeling of molecular blood-brain barrier permeability. Preprint posted online July. 2024;27. https:\/\/doi.org\/10.1101\/2024.07.26.24311027.","DOI":"10.1101\/2024.07.26.24311027"},{"key":"2304_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222312654","author":"F Mo","year":"2021","unstructured":"Mo F, Pellerino A, Soffietti R, Rud\u00e0 R. Blood-brain barrier in brain tumors: biology and clinical relevance. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms222312654.","journal-title":"Int J Mol Sci"},{"key":"2304_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1132077","author":"P Moyaert","year":"2023","unstructured":"Moyaert P, Padrela BE, Morgan CA, et al. Imaging blood-brain barrier dysfunction: a state-of-the-art review from a clinical perspective. Front Aging Neurosci. 2023. https:\/\/doi.org\/10.3389\/fnagi.2023.1132077.","journal-title":"Front Aging Neurosci"},{"key":"2304_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-025-03598-x","author":"Z Kovbasyuk","year":"2025","unstructured":"Kovbasyuk Z, Tefera E, Li C, Baete SH, Steriade C. Imaging brain inflammation and blood brain barrier permeability in neurological and psychiatric diseases: a review. J Neuroinflammation. 2025. https:\/\/doi.org\/10.1186\/s12974-025-03598-x.","journal-title":"J Neuroinflammation"},{"issue":"6","key":"2304_CR42","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.pathol.2023.05.003","volume":"55","author":"M Zuba\u013e","year":"2023","unstructured":"Zuba\u013e M, V\u00fdmolov\u00e1 B, Matrasov\u00e1 I, et al. Fibroblast activation protein as a potential theranostic target in brain metastases of diverse solid tumours. Pathology. 2023;55(6):806\u201317. https:\/\/doi.org\/10.1016\/j.pathol.2023.05.003.","journal-title":"Pathology"},{"key":"2304_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13133304","author":"E Balaziova","year":"2021","unstructured":"Balaziova E, Vymola P, Hrabal P, et al. Fibroblast activation protein expressing mesenchymal cells promote glioblastoma angiogenesis. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13133304.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"2304_CR44","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1158\/1078-0432.CCR-23-0493","volume":"30","author":"PM Galbo","year":"2024","unstructured":"Galbo PM, Madsen AT, Liu Y, et al. Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma. Clin Cancer Res. 2024;30(4):865\u201376. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-0493.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"2304_CR45","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.2967\/jnumed.123.267151","volume":"65","author":"C Oster","year":"2024","unstructured":"Oster C, Kessler L, Blau T, et al. The role of fibroblast activation protein in glioblastoma and gliosarcoma: a comparison of tissue, 68Ga-FAPI-46 PET data, and survival data. J Nucl Med. 2024;65(8):1217\u201323. https:\/\/doi.org\/10.2967\/jnumed.123.267151.","journal-title":"J Nucl Med"},{"key":"2304_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.854658","author":"R Huang","year":"2022","unstructured":"Huang R, Pu Y, Huang S, et al. FAPI-PET\/CT in cancer imaging: a potential novel molecule of the century. Front Oncol. 2022. https:\/\/doi.org\/10.3389\/fonc.2022.854658.","journal-title":"Front Oncol"},{"key":"2304_CR47","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20220463","author":"M Hotta","year":"2023","unstructured":"Hotta M, Rieger AC, Jafarvand MG, et al. Non-oncologic incidental uptake on FAPI PET\/ CT imaging. Br J Radiol. 2023. https:\/\/doi.org\/10.1259\/bjr.20220463.","journal-title":"Br J Radiol"},{"key":"2304_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-025-00887-9","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Xu M, Wang Y, et al. Characteristics of 18F-FAPI-04 PET\/CT in patients with peritoneal metastasis and to predict treatment efficacy, a head-to-head comparison with 18F-FDG PET\/CT. Cancer Imaging. 2025. https:\/\/doi.org\/10.1186\/s40644-025-00887-9.","journal-title":"Cancer Imaging"},{"key":"2304_CR49","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.37349\/etat.2024.00276","volume":"5","author":"ID Dev","year":"2024","unstructured":"Dev ID, Puranik AD, Rangarajan V, et al. Preliminary evaluation of FAPI-04-PET\/CT for differentiating recurrence and post-treatment changes in high-grade gliomas. Exploration of Targeted Anti-tumor Therapy. 2024;5:1289\u201396. https:\/\/doi.org\/10.37349\/etat.2024.00276.","journal-title":"Exploration of Targeted Anti-tumor Therapy"},{"key":"2304_CR50","doi-asserted-by":"publisher","unstructured":"Wu C, Kurniawan A, Ming Z et al. Bridging the gaps in fibroblast activation protein targeted radionuclide therapy: a translational perspective. Eur J Nucl Med Mol Imaging. Springer. Preprint posted online. 2026. https:\/\/doi.org\/10.1007\/s00259-025-07711-3","DOI":"10.1007\/s00259-025-07711-3"},{"key":"2304_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14143315","author":"R Ando","year":"2022","unstructured":"Ando R, Sakai A, Iida T, Kataoka K, Mizutani Y, Enomoto A. Good and bad stroma in pancreatic cancer: relevance of functional states of cancer-associated fibroblasts. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14143315.","journal-title":"Cancers (Basel)"},{"issue":"6","key":"2304_CR52","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","volume":"25","author":"BC \u00d6zdemir","year":"2014","unstructured":"\u00d6zdemir BC, Pentcheva-Hoang T, Carstens JL, et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell. 2014;25(6):719\u201334. https:\/\/doi.org\/10.1016\/j.ccr.2014.04.005.","journal-title":"Cancer Cell"},{"issue":"7","key":"2304_CR53","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1007\/s00259-023-06179-3","volume":"50","author":"G Treglia","year":"2023","unstructured":"Treglia G, Albano D. FAPI PET\/CT in infectious, inflammatory, and rheumatological diseases: \u201cwatch it like a hawk\u201d or \u201cone swallow does not make a summer\u201d? Eur J Nucl Med Mol Imaging. 2023;50(7):1848\u201350. https:\/\/doi.org\/10.1007\/s00259-023-06179-3.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"2304_CR54","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1007\/s00259-023-06146-y","volume":"50","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wang R, Zhang X, et al. Diagnostic efficiency of [68 Ga]Ga-DOTA-FAPI-04 in differentiating periprosthetic hip joint infection and aseptic failure. Eur J Nucl Med Mol Imaging. 2023;50(7):1919\u201328. https:\/\/doi.org\/10.1007\/s00259-023-06146-y.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2304_CR55","doi-asserted-by":"publisher","DOI":"10.1093\/bjr\/tqaf020","author":"M Desaulniers","year":"2025","unstructured":"Desaulniers M, Rousseau \u00c9, Pabst KM. Clinical and research applications of fibroblast activation protein-\u03b1 inhibitor tracers: a review. Br J Radiol. 2025. https:\/\/doi.org\/10.1093\/bjr\/tqaf020.","journal-title":"Br J Radiol"},{"issue":"3","key":"2304_CR56","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s00259-024-06986-2","volume":"52","author":"K Zhong","year":"2025","unstructured":"Zhong K, Chen H, Hou P, et al. Comparison of [18F]FAPI-42 and [18F]FDG PET\/CT in the evaluation of systemic vasculitis. Eur J Nucl Med Mol Imaging. 2025;52(3):1083\u201394. https:\/\/doi.org\/10.1007\/s00259-024-06986-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2304_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/ph17060716","author":"D Albano","year":"2024","unstructured":"Albano D, Rizzo A, Slart RHJA, et al. The role of fibroblast activation protein inhibitor positron emission tomography in inflammatory and infectious diseases: an updated systematic review. Pharmaceuticals (Basel). 2024. https:\/\/doi.org\/10.3390\/ph17060716.","journal-title":"Pharmaceuticals (Basel)"},{"key":"2304_CR58","doi-asserted-by":"crossref","unstructured":"Yang H, Zhong JT, Zhou SH, Han HM. Roles of GLUT-1 and HK-II expression in the biological behavior of head and neck cancer. Oncotarget. Published online 2019. www.oncotarget.com.","DOI":"10.18632\/oncotarget.24684"},{"key":"2304_CR59","doi-asserted-by":"crossref","unstructured":"Muzi M, Freeman SD, Burrows RC et al. Kinetic characterization of hexokinase isoenzymes from glioma cells: Implications for FDG imaging of human brain tumors. El Sevier. Published online 2001.","DOI":"10.1016\/S0969-8051(00)00201-8"},{"issue":"5","key":"2304_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14051103","volume":"14","author":"A Verger","year":"2022","unstructured":"Verger A, Kas A, Darcourt J, Guedj E. PET imaging in neuro-oncology: an update and overview of a rapidly growing area. Cancers (Basel). 2022;14(5):1103. https:\/\/doi.org\/10.3390\/cancers14051103.","journal-title":"Cancers (Basel)"},{"key":"2304_CR61","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jocn.2020.11.025","volume":"83","author":"Y Li","year":"2021","unstructured":"Li Y, Zhang ZX, Huang GH, et al. A systematic review of multifocal and multicentric glioblastoma. J Clin Neurosci. 2021;83:71\u20136. https:\/\/doi.org\/10.1016\/j.jocn.2020.11.025.","journal-title":"J Clin Neurosci"},{"key":"2304_CR62","doi-asserted-by":"publisher","unstructured":"Zhang ZX, Chen JX, Shi BZ, et al. Multifocal glioblastoma\u2014two case reports and literature review. Chin Neurosurg J. 2021;7(1). https:\/\/doi.org\/10.1186\/s41016-020-00223-z.","DOI":"10.1186\/s41016-020-00223-z"},{"key":"2304_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s41984-025-00436-3","author":"A Iranmehr","year":"2025","unstructured":"Iranmehr A, SohrabiAsl M, Pour-Rashidi A, Shirani M, Nahang FH. Multifocal and multicentric glioblastoma: clinical characteristics and treatment outcomes in a monocentric series of twelve cases. Egypt J Neurosurg. 2025. https:\/\/doi.org\/10.1186\/s41984-025-00436-3.","journal-title":"Egypt J Neurosurg"},{"key":"2304_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13122960","author":"AJ Fordham","year":"2021","unstructured":"Fordham AJ, Hacherl CC, Patel N, et al. Differentiating glioblastomas from solitary brain metastases: an update on the current literature of advanced imaging modalities. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13122960.","journal-title":"Cancers (Basel)"},{"issue":"8","key":"2304_CR65","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1093\/neuonc\/nor054","volume":"13","author":"C La Foug\u00e8re","year":"2011","unstructured":"La Foug\u00e8re C, Suchorska B, Bartenstein P, Kreth FW, Tonn JC. Molecular imaging of gliomas with PET: opportunities and limitations. Neuro Oncol. 2011;13(8):806\u201319. https:\/\/doi.org\/10.1093\/neuonc\/nor054.","journal-title":"Neuro Oncol"},{"key":"2304_CR66","doi-asserted-by":"publisher","unstructured":"Amalo RB, Budiawan H, Darmawan B. Comparative Insights into 18F-FDG and 68Ga-FAPI PET Imaging in Glioma: Diagnostic Value, Tumor Grading, and Clinical Implications. Mol Imaging Radionucl Ther. Published online March. 2026;24. https:\/\/doi.org\/10.4274\/mirt.galenos.2026.84704.","DOI":"10.4274\/mirt.galenos.2026.84704"},{"key":"2304_CR67","doi-asserted-by":"crossref","unstructured":"Padma MV, Said S, Jacobs M et al. Prediction of Pathology and Survival by FDG PET in Gliomas. Vol 64. 2003.","DOI":"10.1023\/A:1025665820001"},{"issue":"5","key":"2304_CR68","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/nop\/npab027","volume":"8","author":"EE Parent","year":"2021","unstructured":"Parent EE, Johnson DR, Gleason T, Villanueva-Meyer JE. Neuro-oncology practice clinical debate: FDG PET to differentiate glioblastoma recurrence from treatment-related changes. Neurooncol Pract. 2021;8(5):518\u201325. https:\/\/doi.org\/10.1093\/nop\/npab027.","journal-title":"Neurooncol Pract"},{"issue":"5","key":"2304_CR69","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/neuonc\/nos012","volume":"14","author":"C Colavolpe","year":"2012","unstructured":"Colavolpe C, Chinot O, Metellus P, et al. FDG-PET predicts survival in recurrent high-grade gliomas treated with bevacizumab and irinotecan. Neuro Oncol. 2012;14(5):649\u201357. https:\/\/doi.org\/10.1093\/neuonc\/nos012.","journal-title":"Neuro Oncol"},{"key":"2304_CR70","doi-asserted-by":"publisher","unstructured":"Graham MS, Krebs S, Bale T, et al. Value of [18F]-FDG positron emission tomography in patients with recurrent glioblastoma receiving bevacizumab. Neurooncol Adv. 2020;2(1). https:\/\/doi.org\/10.1093\/noajnl\/vdaa050.","DOI":"10.1093\/noajnl\/vdaa050"},{"key":"2304_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.683793","author":"K Shen","year":"2021","unstructured":"Shen K, Liu B, Zhou X, et al. The evolving role of 18F-FDG PET\/CT in diagnosis and prognosis prediction in progressive prostate cancer. Front Oncol. 2021. https:\/\/doi.org\/10.3389\/fonc.2021.683793.","journal-title":"Front Oncol"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-026-02304-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-026-02304-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-026-02304-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:11:00Z","timestamp":1791817860000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-026-02304-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":71,"alternative-id":["2304"],"URL":"https:\/\/doi.org\/10.1007\/s12149-026-02304-y","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,12]]},"assertion":[{"value":"29 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided informed consent for publication of anonymized imaging data included in this manuscript.","order":2,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all individual participants included in this study.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee (No. DP.04.03\/D.XIV.6.5\/454\/2024).","order":4,"name":"Ethics","label":"<b>Ethical approval<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","label":"<b>Informed consent<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}}]}}